Literature DB >> 26703287

In vivo subjective and objective longitudinal chromatic aberration after bilateral implantation of the same design of hydrophobic and hydrophilic intraocular lenses.

Maria Vinas1, Carlos Dorronsoro2, Nuria Garzón2, Francisco Poyales2, Susana Marcos2.   

Abstract

PURPOSE: To measure the longitudinal chromatic aberration in vivo using psychophysical and wavefront-sensing methods in patients with bilateral implantation of monofocal intraocular lenses (IOLs) of similar aspheric design but different materials (hydrophobic Podeye and hydrophilic Poday).
SETTING: Instituto de Optica, Consejo Superior de Investigaciones Cientificas, Madrid, Spain.
DESIGN: Prospective observational study.
METHODS: Measurements were performed with the use of psychophysical (480 to 700 nm) and wavefront-sensing (480 to 950 nm) methods using a custom-developed adaptive optics system. Chromatic difference-of-focus curves were obtained from best-focus data at each wavelength, and the longitudinal chromatic aberration was obtained from the slope of linear regressions to those curves.
RESULTS: The longitudinal chromatic aberration from psychophysical measurements was 1.37 diopters (D) ± 0.08 (SD) (hydrophobic) and 1.21 ± 0.08 D (hydrophilic). From wavefront-sensing, the longitudinal chromatic aberration was 0.88 ± 0.07 D and 0.73 ± 0.09 D, respectively. At 480 to 950 nm, the longitudinal chromatic aberration was 1.27 ± 0.09 D (hydrophobic) and 1.02 ± 0.13 D (hydrophilic). The longitudinal chromatic aberration was consistently higher in eyes with the hydrophobic IOL than in eyes with the hydrophilic IOL (a difference of 0.16 D and 0.15 D, respectively). Similar to findings in young phakic eyes, the longitudinal chromatic aberration from the psychophysical method was consistently higher than from wavefront-sensing, by 0.48 D (35.41%) for the hydrophobic IOL and 0.48 D (39.43%) for the hydrophilic IOL.
CONCLUSION: Longitudinal chromatic aberrations were smaller with hydrophilic IOLs than with hydrophobic IOLs of the same design. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26703287     DOI: 10.1016/j.jcrs.2015.11.009

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  5 in total

1.  Comparison of vision through surface modulated and spatial light modulated multifocal optics.

Authors:  Maria Vinas; Carlos Dorronsoro; Aiswaryah Radhakrishnan; Clara Benedi-Garcia; Edward Anthony LaVilla; Jim Schwiegerling; Susana Marcos
Journal:  Biomed Opt Express       Date:  2017-03-03       Impact factor: 3.732

Review 2.  Vision science and adaptive optics, the state of the field.

Authors:  Susana Marcos; John S Werner; Stephen A Burns; William H Merigan; Pablo Artal; David A Atchison; Karen M Hampson; Richard Legras; Linda Lundstrom; Geungyoung Yoon; Joseph Carroll; Stacey S Choi; Nathan Doble; Adam M Dubis; Alfredo Dubra; Ann Elsner; Ravi Jonnal; Donald T Miller; Michel Paques; Hannah E Smithson; Laura K Young; Yuhua Zhang; Melanie Campbell; Jennifer Hunter; Andrew Metha; Grazyna Palczewska; Jesse Schallek; Lawrence C Sincich
Journal:  Vision Res       Date:  2017-02-27       Impact factor: 1.886

3.  Temporal multiplexing to simulate multifocal intraocular lenses: theoretical considerations.

Authors:  Vyas Akondi; Carlos Dorronsoro; Enrique Gambra; Susana Marcos
Journal:  Biomed Opt Express       Date:  2017-06-23       Impact factor: 3.732

4.  Vision is protected against blue defocus.

Authors:  Clara Benedi-Garcia; Maria Vinas; Carlos Dorronsoro; Stephen A Burns; Eli Peli; Susana Marcos
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

5.  Through-Focus Energy Efficiency and Longitudinal Chromatic Aberration of Three Presbyopia-Correcting Intraocular Lenses.

Authors:  María S Millán; Fidel Vega
Journal:  Transl Vis Sci Technol       Date:  2020-11-09       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.